The Immuno Bill is a Reality! Guidance for the New "Medicare Part B-ID"

Wednesday, November 2, 2022 - 14:00 to 15:00

VIEW ON-DEMAND

After participating in this webinar, the attendee will be able to:

  1. Understand the significance of the moment, including the experience of testifying before Congress, questions asked, and concerns revealed.
  2. Identify the target population for the new benefit, strategies to identify eligible patients, and how to enroll patients.
  3. Understand logistics of the coverage, requirements of the prescription, and how the coverage works.

A 1-page, summary handout on Lifelong Immunosuppressive Drug Coverage for Kidney Transplant is available with the on-demand recording.

Speakers:

  • Matthew Cooper, MD, FAST • Director, Kidney and Pancreas Transplantation, MedStar Georgetown Transplant Institute, Washington, DC
  • Nancy Edgington, LCSW III, CCTSW • Lead Kidney Transplant Social Worker, Yale New Haven Hospital, New Haven, CT
  • Jennifer McDermott, PharmD, BCTXP, BCPS • Clinical Pharmacy Specialist, Solid Organ Transplant, Spectrum Health, Grand Rapids, MI

Moderator:

  • Lisa Potter, PharmD, BCTXP, FCCP, FAST • Clinical Coordinator, Organ Transplant, University of Chicago Medicine, Chicago, IL
- - - - -

This topic was suggested by the AST Education Committee for inclusion in the 2022-2023 T3 webinar series. The Committee would like to thank the leadership of AST's Transplant Pharmacy Community of Practice (TxPharm COP) for their feedback on session speakers. Learn more about AST's COPs at www.myast.org/cops.

Series category: 
T3: Timely Topics in Transplantion

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.